Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / Development of paraffin-based expression profiles to predict minimal vs. substantial risk of disease progression using retrospective datasets

Development of paraffin-based expression profiles to predict minimal vs. substantial risk of disease progression using retrospective datasets

113

No coordinating investigator defined.

No involved investigator sites defined.

UNKNOWN
Breast and Gynecologic Cancers Research

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.

Announcement 01/30/2017

Please visit http://www.compass. fhcrc.org/meeting/reg_edrn/edrnsc.aspx for information and to register for the 31st EDRN Steering Committee Meeting in Tempe, AZ, from March 6-9, 2017.

Announcement